Artri Ajo King Tablets Recalled Due to Undeclared Diclofenac
The FDA is recalling Artri Ajo King tablets nationwide after finding they contain undeclared diclofenac, a prescription anti-inflammatory drug. Affected bottles (lot LTARTKNGOMG30220, expiring December 2025) were sold on Amazon.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall of a product containing an undeclared prescription drug sold without FDA approval. Although no illnesses or deaths are reported in the source, FDA Class I classification mandates a minimum severity score of 4 per the recall severity rubric.
Plain-English summary
The FDA is recalling Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, a 500 mg product sold in 100-count bottles. The product was manufactured by Plantas Medicinales de Mexico and distributed nationwide in the United States through Amazon.com, Inc. Approximately 2,441 bottles are affected.
FDA laboratory analysis discovered that the product contains undeclared diclofenac, a prescription-strength non-steroidal anti-inflammatory drug (NSAID). The product was marketed without an approved New Drug Application (NDA), meaning it was not authorized by the FDA for human use in this formulation. Diclofenac poses serious health risks, including potential interactions with other medications and adverse effects in individuals with kidney disease, cardiovascular conditions, or gastrointestinal issues.
This recall affects consumers who purchased Artri Ajo King tablets in the United States. The affected product has lot number LTARTKNGOMG30220 with an expiration date of December 2025.
Consumers should not use this product. If you have purchased affected bottles, stop using the product immediately. Consult with a healthcare provider if you have taken the product or have questions about your health.
The recalled product
- Product
- Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B092P4615M, UPC 7 501031 111190
- Manufacturer
- Amazon.com, Inc.
- Category
- Drug
- Hazard
- undeclared-diclofenac
- unapproved-formulation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: LTARTKNGOMG30220
- Exp. Diciembre 2025 (December 2025).
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27